In-Silico Tool for Predicting, Scanning, and Designing Defensins

The book entitled "In-Silico Tool for Predicting, Scanning, and Designing Defensins deals with the study to predict an effective epitope-based vaccine against human herpes virus type 1 glycoprotein B. Development in immune genetics will enhance apprehension of the impact of genetic factors on the inter-individual and inter-population variations in immune responses to vaccines that could be helpful for progress new vaccine strategies. In-silico/reverse vaccinology had replaced conventional culture-based vaccines because it reduces the cost required for laboratory investigation of pathogens, and also speeds up the time needed to achieve the results. Therefore, using immunoinformatics approaches to predict this new kind of vaccine could be magnificently additive. Normally, the investigation of the binding affinity of antigenic peptides to the MHC class 1 and class 2 molecules is the main goal when predicting epitopes. Using such tools and information leads to the development of new vaccines. While these approaches permit the optimization of a vaccine for a species population, the problem can also be reformulated to design a 'universal vaccine'.